MECP2 and Rett syndrome: The molecular mechanisms by which MeCP2 regulates transcription have been a subject of active investigation, though the genetic data cataloging the sites of missense mutations in RTT patients suggests that the binding of MeCP2 to chromatin and its interaction with the NCoR-SMRT complex are critical.